Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-062707

EVP, Research & CSO sold 1,375 shares at $36.94 ($50,793)

  • EVP, Research & CSO acquired 1,375 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-11-02 Option exercise +1,375 $1.53 $2,104 109,075 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2021-11-02 Sale −1,375 $36.94 $50,793 107,700 D: show line 2 in the form
Open-market sales · 1,375 sh · avg $36.94 · $50,793

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-11-02 Option exercise · Stock Option (Right to Buy) −1,375 247,005 D: show line 3 in the form
Loading xslF345X03/doc4.xml…